The	O
class	B-protein
II	I-protein
trans-activator	I-protein
CIITA	I-protein
interacts	O
with	O
the	O
TBP-associated	B-protein
factor	I-protein
TAFII32	I-protein
.	O

The	O
class	B-protein
II	I-protein
trans-	I-protein
activator	I-protein
(	O
CIITA	B-protein
)	O
is	O
the	O
main	O
transcriptional	O
co-activator	O
for	O
the	O
expression	O
of	O
MHC	B-protein
class	I-protein
II	I-protein
proteins	I-protein
.	O

Its	O
N-terminal	B-protein
125	I-protein
amino	I-protein
acids	I-protein
function	O
as	O
an	O
independent	B-protein
transcriptional	I-protein
activation	I-protein
domain	I-protein
.	O

Analyses	O
of	O
the	O
primary	B-protein
amino	I-protein
acid	I-protein
sequence	I-protein
of	O
the	O
activation	B-protein
domain	I-protein
predict	O
the	O
presence	O
of	O
three	O
alpha-helices	B-protein
,	O
each	O
with	O
a	O
high	O
proportion	O
of	O
acidic	O
residues	O
.	O

Using	O
site-directed	O
mutagenesis	O
,	O
we	O
found	O
that	O
two	O
of	O
these	O
predicted	O
alpha-helices	B-protein
are	O
required	O
for	O
full	O
transcriptional	O
activation	O
by	O
CIITA	B-protein
.	O

Moreover	O
,	O
a	O
CIITA	B-protein
protein	I-protein
in	O
which	O
both	O
functional	O
alpha-helices	B-protein
have	O
been	O
deleted	O
displays	O
a	O
dominant	O
negative	O
phenotype	O
.	O

This	O
activation	B-protein
domain	I-protein
of	O
CIITA	B-protein
interacts	O
with	O
the	O
32	B-protein
kDa	I-protein
subunit	I-protein
of	O
the	O
general	B-protein
transcription	I-protein
complex	I-protein
TFIID	B-protein
,	O
TAFII32	B-protein
.	O

Decreased	O
transcriptional	O
activation	O
by	O
N-terminal	B-protein
deletions	I-protein
of	O
CIITA	B-protein
is	O
correlated	O
directly	O
with	O
their	O
reduced	O
binding	O
to	O
TAFII32	B-protein
.	O

We	O
conclude	O
that	O
interactions	O
between	O
TAFII32	B-protein
and	O
CIITA	B-protein
are	O
responsible	O
for	O
activation	O
of	O
class	B-DNA
II	I-DNA
genes	I-DNA
.	O

2522-2528	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
©	NULL
1997	NULL
Oxford	NULL
University	NULL
Press	NULL
The	NULL
class	NULL
II	NULL
trans-activator	NULL
CIITA	NULL
interacts	NULL
with	NULL
the	NULL
TBP-associated	NULL
factor	NULL
TAF	NULL
,	NULL
,32	NULL
Joseph	NULL
D.	NULL
Fontes	NULL
,	NULL
Bing	NULL
Jiang	NULL
and	NULL
B.	NULL
Matija	NULL
Peterlin*	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143-0724	NULL
,	NULL
USA	NULL
Received	NULL
December	NULL
11	NULL
,	NULL
1996	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
April	NULL
24	NULL
,	NULL
1997	NULL
ABSTRACT	NULL
The	NULL
class	NULL
II	NULL
trans-activator	NULL
(	NULL
CIITA	NULL
)	NULL
is	NULL
the	NULL
main	NULL
transcriptional	NULL
co-activator	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
proteins	NULL
.	NULL

Its	NULL
N-terminal	NULL
125	NULL
amino	NULL
acids	NULL
function	NULL
as	NULL
an	NULL
independent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Analyses	NULL
of	NULL
the	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
predict	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
o-helices	NULL
,	NULL
each	NULL
with	NULL
a	NULL
high	NULL
proportion	NULL
of	NULL
acidic	NULL
residues	NULL
.	NULL

Using	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
we	NULL
found	NULL
that	NULL
two	NULL
of	NULL
these	NULL
predicted	NULL
o-helices	NULL
are	NULL
required	NULL
for	NULL
full	NULL
transcriptional	NULL
activation	NULL
by	NULL
CIITA	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
CIITA	NULL
protein	NULL
in	NULL
which	NULL
both	NULL
functional	NULL
a-helices	NULL
have	NULL
been	NULL
deleted	NULL
displays	NULL
a	NULL
dominant	NULL
negative	NULL
phenotype	NULL
.	NULL

This	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
interacts	NULL
with	NULL
the	NULL
32	NULL
kDa	NULL
subunit	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
complex	NULL
TFIID	NULL
,	NULL
TAF,32	NULL
.	NULL

Decreased	NULL
transcriptional	NULL
activation	NULL
by	NULL
N-terminal	NULL
deletions	NULL
of	NULL
CIITA	NULL
is	NULL
correlated	NULL
directly	NULL
with	NULL
their	NULL
reduced	NULL
binding	NULL
to	NULL
TAF	NULL
,	NULL
32	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
interactions	NULL
between	NULL
TAF	NULL
,	NULL
32	NULL
and	NULL
CIITA	NULL
are	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

INTRODUCTION	NULL
Cell	NULL
type-specific	NULL
and	NULL
IFNy-inducible	NULL
expression	NULL
of	NULL
genes	NULL
in	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
class	NULL
II	NULL
)	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
function	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Congenital	NULL
lack	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
results	NULL
in	NULL
the	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
known	NULL
as	NULL
type	NULL
II	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
BLS	NULL
II	NULL
)	NULL
(	NULL
1,2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
aberrant	NULL
or	NULL
over-expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
autoimmune	NULL
diseases	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcriptional	NULL
initiation	NULL
(	NULL
reviewed	NULL
in	NULL
2,4-7	NULL
)	NULL
and	NULL
requires	NULL
the	NULL
class	NULL
II	NULL
trans-activator	NULL
(	NULL
CIITA	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

CHTA	NULL
was	NULL
isolated	NULL
by	NULL
genetic	NULL
complementation	NULL
of	NULL
a	NULL
class	NULL
II-negative	NULL
BLS	NULL
II	NULL
cell	NULL
line	NULL
®	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
IFNy	NULL
requires	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
CIITA	NULL
(	NULL
9,10	NULL
)	NULL
.	NULL

CIITA	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
its	NULL
extinction	NULL
in	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
(	NULL
11	NULL
)	NULL
.	NULL

By	NULL
activating	NULL
expression	NULL
of	NULL
the	NULL
invariant	NULL
chain	NULL
,	NULL
HLA-DMA	NULL
and	NULL
HLA-DMB	NULL
,	NULL
CIITA	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
other	NULL
aspects	NULL
of	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
(	NULL
12,13	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
disruption	NULL
of	NULL
the	NULL
CIITA	NULL
gene	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
all	NULL
tissues	NULL
except	NULL
for	NULL
isolated	NULL
thymic	NULL
epithelial	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Normal	NULL
development	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
severely	NULL
impaired	NULL
and	NULL
other	NULL
hallmarks	NULL
of	NULL
the	NULL
BLS	NULL
II	NULL
phenotype	NULL
were	NULL
faithfully	NULL
reproduced	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CHTA	NULL
functions	NULL
as	NULL
the	NULL
'master	NULL
switch	NULL
'	NULL
for	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
all	NULL
cells	NULL
examined	NULL
to	NULL
date	NULL
.	NULL

Like	NULL
many	NULL
proteins	NULL
involved	NULL
in	NULL
transcriptional	NULL
regulation	NULL
,	NULL
the	NULL
1130	NULL
amino	NULL
acid	NULL
CIHITA	NULL
protein	NULL
has	NULL
a	NULL
modular	NULL
structure	NULL
.	NULL

The	NULL
N-terminus	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
this	NULL
region	NULL
may	NULL
function	NULL
as	NULL
an	NULL
activation	NULL
domain	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Riley	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
1	NULL
to	NULL
125	NULL
could	NULL
activate	NULL
transcription	NULL
via	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Gal4	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
full-length	NULL
protein	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Additional	NULL
experiments	NULL
demonstrated	NULL
that	NULL
a	NULL
third	NULL
of	NULL
this	NULL
activity	NULL
remained	NULL
with	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
37	NULL
to	NULL
125	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

mapped	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
using	NULL
LexA	NULL
fusion	NULL
proteins	NULL
and	NULL
demonstrated	NULL
that	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
1	NULL
to	NULL
114	NULL
,	NULL
which	NULL
contain	NULL
~80	NULL
%	NULL
of	NULL
the	NULL
acidic	NULL
amino	NULL
acid	NULL
region	NULL
,	NULL
produced	NULL
near	NULL
wild-type	NULL
levels	NULL
of	NULL
transcriptional	NULL
activation	NULL
in	NULL
yeast	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
when	NULL
the	NULL
N-terminal	NULL
300	NULL
amino	NULL
acids	NULL
of	NULL
CIITA	NULL
were	NULL
replaced	NULL
with	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
from	NULL
herpes	NULL
simplex	NULL
virus	NULL
1	NULL
(	NULL
HSV1	NULL
)	NULL
the	NULL
chimera	NULL
activated	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
to	NULL
levels	NULL
~25	NULL
%	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
CIITA	NULL
(	NULL
16	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
shares	NULL
functional	NULL
homology	NULL
with	NULL
VP16	NULL
and	NULL
that	NULL
the	NULL
C-terminal	NULL
830	NULL
amino	NULL
acids	NULL
of	NULL
CIITA	NULL
are	NULL
involved	NULL
in	NULL
targeting	NULL
the	NULL
protein	NULL
to	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

Using	NULL
acidic	NULL
activators	NULL
as	NULL
models	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
structure-function	NULL
relationships	NULL
of	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
CITA	NULL
yielded	NULL
three	NULL
putative	NULL
(	NULL
-helices	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
a-helices	NULL
contains	NULL
~40	NULL
%	NULL
acidic	NULL
residues	NULL
.	NULL

These	NULL
predicted	NULL
acidic	NULL
a-helices	NULL
provided	NULL
a	NULL
reasonable	NULL
starting	NULL
point	NULL
for	NULL
structural	NULL
analyses	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CITA	NULL
.	NULL

Mutational	NULL
analyses	NULL
of	NULL
these	NULL
structures	NULL
demonstrated	NULL
that	NULL
two	NULL
of	NULL
these	NULL
(	NULL
-helices	NULL
are	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
CIITA	NULL
.	NULL

A	NULL
CIITA	NULL
protein	NULL
in	NULL
which	NULL
these	NULL
two	NULL
active	NULL
a-helices	NULL
were	NULL
deleted	NULL
displayed	NULL
a	NULL
dominant	NULL
negative	NULL
phenotype	NULL
in	NULL
co-transfection	NULL
experiments	NULL
with	NULL
wild-type	NULL
CIITA	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
studies	NULL
revealed	NULL
that	NULL
the	NULL
N-terminus	NULL
of	NULL
CIITA	NULL
binds	NULL
to	NULL
the	NULL
32	NULL
kDa	NULL
subunit	NULL
of	NULL
TFIID	NULL
(	NULL
TAFpg32	NULL
)	NULL
and	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
two	NULL
active	NULL
(	NULL
-helices	NULL
from	NULL
CIITA	NULL
correlates	NULL
directly	NULL
with	NULL
loss	NULL
of	NULL
its	NULL
binding	NULL
to	NULL
TAFg32	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
CIITA	NULL
and	NULL
TAFpg32	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
in	NULL
the	NULL
*To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
:	NULL
+1	NULL
415	NULL
476	NULL
1291	NULL
;	NULL
Fax	NULL
:	NULL
+1	NULL
415	NULL
502	NULL
5081	NULL
;	NULL
Email	NULL
:	NULL
matija	NULL
@	NULL
itsa.ucsf.edu	NULL
transcriptional	NULL
activation	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
a	NULL
functional	NULL
interaction	NULL
between	NULL
a	NULL
cellular	NULL
co-activator	NULL
and	NULL
a	NULL
TAF	NULL
,	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
construction	NULL
and	NULL
mutagenesis	NULL
CIITA	NULL
cDNA	NULL
from	NULL
plasmid	NULL
pCDNAIV/CIITA	NULL
(	NULL
10	NULL
)	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
pSVSPORT-1	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
,	NULL
Gaithersburgh	NULL
,	NULL
MD	NULL
)	NULL
at	NULL
the	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
1	NULL
to	NULL
161	NULL
in	NULL
pSVCIITAAN	NULL
was	NULL
achieved	NULL
by	NULL
amplification	NULL
of	NULL
CITA	NULL
cDNA	NULL
from	NULL
position	NULL
599	NULL
to	NULL
3512	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
ligated	NULL
into	NULL
pSVSPORT-1	NULL
using	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
in	NULL
the	NULL
PCR	NULL
primers	NULL
.	NULL

Deletions	NULL
of	NULL
(	NULL
-helices	NULL
(	NULL
pSVCIITAAah1	NULL
,	NULL
pSVCIITAAah2	NULL
,	NULL
pSVCIHITAAah3	NULL
and	NULL
pSVCIITAAah12	NULL
)	NULL
and	NULL
alanine	NULL
to	NULL
proline	NULL
[	NULL
pSVCIITA	NULL
(	NULL
AAP	NULL
)	NULL
]	NULL
glycine	NULL
to	NULL
proline	NULL
[	NULL
pSVCIITA	NULL
(	NULL
GS8P	NULL
)	NULL
]	NULL
and	NULL
acidic	NULL
amino	NULL
acid	NULL
substitutions	NULL
[	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-N	NULL
)	NULL
and	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-NC	NULL
)	NULL
]	NULL
were	NULL
generated	NULL
in	NULL
pSVCIITA	NULL
using	NULL
the	NULL
Transformer	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
from	NULL
Clontech	NULL
(	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

pGal4C	NULL
(	NULL
1-143	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
amplifying	NULL
CIITA	NULL
cDNA	NULL
from	NULL
base	NULL
pair	NULL
116	NULL
to	NULL
429	NULL
by	NULL
PCR	NULL
,	NULL
followed	NULL
by	NULL
ligating	NULL
the	NULL
PCR	NULL
product	NULL
into	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
fusion	NULL
vector	NULL
pSG424	NULL
(	NULL
17	NULL
)	NULL
using	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
in	NULL
the	NULL
PCR	NULL
primers	NULL
.	NULL

pGal4CAah1	NULL
,	NULL
pGal4CAah2	NULL
,	NULL
pGal4CAah3	NULL
and	NULL
pGal4CAah12	NULL
were	NULL
constructed	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
templates	NULL
for	NULL
the	NULL
PCR	NULL
reactions	NULL
were	NULL
the	NULL
appropriate	NULL
mutated	NULL
CIITA	NULL
cDNA	NULL
.	NULL

Plasmids	NULL
expressing	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
GSTCHITA	NULL
(	NULL
I-143	NULL
)	NULL
and	NULL
GSTCIHITA	NULL
(	NULL
1-143	NULL
)	NULL
A¥ah12	NULL
were	NULL
constructed	NULL
by	NULL
amplifying	NULL
CIHITA	NULL
cDNA	NULL
from	NULL
base	NULL
pair	NULL
116	NULL
to	NULL
429	NULL
by	NULL
PCR	NULL
,	NULL
using	NULL
pSVCIITA	NULL
and	NULL
pSVCIITAAah12	NULL
respectively	NULL
as	NULL
template	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
vector	NULL
pCR3	NULL
(	NULL
InVitrogen	NULL
Inc.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
excised	NULL
with	NULL
Bgilll	NULL
(	NULL
in	NULL
the	NULL
5°	NULL
PCR	NULL
primer	NULL
)	NULL
and	NULL
EcoRI	NULL
and	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
prokaryotic	NULL
expression	NULL
vector	NULL
pGEX3X	NULL
(	NULL
Pharmacia	NULL
,	NULL
Upsala	NULL
,	NULL
Sweden	NULL
)	NULL
at	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
.	NULL

pDRASCAT	NULL
has	NULL
been	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
GST-TAFpg32	NULL
prokaryotic	NULL
expression	NULL
vector	NULL
pGEX2ZTK/TAFpq32	NULL
(	NULL
19	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Robert	NULL
Tjian	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transfection	NULL
and	NULL
CAT	NULL
assay	NULL
HeLa	NULL
and	NULL
COS	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
U/ml	NULL
!	NULL

streptomycin	NULL
and	NULL
2	NULL
tmM	NULL
L-glutamine	NULL
.	NULL

Transfection	NULL
of	NULL
HeLa	NULL
(	NULL
1	NULL
ug	NULL
total	NULL
plasmid	NULL
DNA	NULL
)	NULL
and	NULL
COS	NULL
cells	NULL
(	NULL
2	NULL
g	NULL
total	NULL
plasmid	NULL
DNA	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
lipofectamine	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
,	NULL
Gaithersburgh	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
CAT	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
times	NULL
.	NULL

Duplicate	NULL
values	NULL
were	NULL
averaged	NULL
and	NULL
the	NULL
SEM	NULL
calculated	NULL
.	NULL

A	NULL
human	NULL
chorionic	NULL
gonadotropin	NULL
expression	NULL
plasmid	NULL
was	NULL
included	NULL
in	NULL
all	NULL
transfections	NULL
as	NULL
a	NULL
transfection	NULL
efficiency	NULL
control	NULL
,	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
recombinant	NULL
proteins	NULL
in	NULL
Escherichia	NULL
coli	NULL
Recombinant	NULL
proteins	NULL
GSTCIHITA	NULL
(	NULL
I-143	NULL
)	NULL
,	NULL
GSTCIHITA	NULL
(	NULL
1-143	NULL
)	NULL
Aah12	NULL
and	NULL
GST-TAFpg32	NULL
were	NULL
all	NULL
produced	NULL
essentially	NULL
as	NULL
described	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
-	NULL
2523	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Escherichia	NULL
coli	NULL
strain	NULL
DHS5Q	NULL
was	NULL
transformed	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
and	NULL
a	NULL
50	NULL
ml	NULL
overnight	NULL
culture	NULL
from	NULL
a	NULL
single	NULL
colony	NULL
was	NULL
grown	NULL
in	NULL
LB	NULL
broth	NULL
containing	NULL
100	NULL
ug/ml	NULL
ampicillin	NULL
.	NULL

The	NULL
overnight	NULL
culture	NULL
was	NULL
used	NULL
to	NULL
inoculate	NULL
500	NULL
ml	NULL
LB	NULL
broth	NULL
containing	NULL
100	NULL
ug/ml	NULL
ampicillin	NULL
and	NULL
this	NULL
culture	NULL
was	NULL
grown	NULL
to	NULL
an	NULL
ODsgp	NULL
of	NULL
~0.5	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
isopropyl-	NULL
B-D-thiogalacto-side	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
mM	NULL
.	NULL

The	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
3	NULL
h	NULL
,	NULL
the	NULL
bacteria	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
lysed	NULL
in	NULL
4.0	NULL
ml	NULL
EBC-D	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
120	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
5	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
25	NULL
000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
used	NULL
in	NULL
binding	NULL
reactions	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
Nuclear	NULL
extract	NULL
was	NULL
prepared	NULL
from	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
collected	NULL
by	NULL
leukaphoresis	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
B	NULL
cell	NULL
leukemia	NULL
.	NULL

Freshly	NULL
collected	NULL
cells	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
nuclear	NULL
extract	NULL
prepared	NULL
exactly	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
18	NULL
ug/ml	NULL
,	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
BioRad	NULL
Inc.	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
protein	NULL
interaction	NULL
assays	NULL
Recombinant	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
combining	NULL
100	NULL
u	NULL
cleared	NULL
lysate	NULL
from	NULL
E.coli	NULL
,	NULL
350	NULL
ull	NULL
EBC-D	NULL
buffer	NULL
and	NULL
50	NULL
u	NULL
glutathione-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
pre-washed	NULL
in	NULL
EBC-D	NULL
buffer	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
with	NULL
inversion	NULL
for	NULL
60	NULL
min	NULL
and	NULL
the	NULL
Sepharose	NULL
beads	NULL
collected	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
EBC-DS	NULL
(	NULL
EBC-D	NULL
buffer	NULL
containing	NULL
0.075	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
twice	NULL
in	NULL
TGEM200	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mM	NULL
MgC	NULL
)	NULL
h	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
resuspended	NULL
in	NULL
600	NULL
l	NULL
TGEM200	NULL
for	NULL
use	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

For	NULL
binding	NULL
of	NULL
TAFpg32	NULL
to	NULL
GSTCIHITA	NULL
(	NULL
I-144	NULL
)	NULL
or	NULL
GSTCHTA	NULL
(	NULL
I-144	NULL
)	NULL
A¥ah12	NULL
,	NULL
50	NULL
pul	NULL
B	NULL
cell	NULL
nuclear	NULL
extract	NULL
were	NULL
added	NULL
to	NULL
the	NULL
glutathione-Sepharose	NULL
beads	NULL
bound	NULL
with	NULL
the	NULL
appropriate	NULL
GST	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
inversion	NULL
and	NULL
the	NULL
beads	NULL
collected	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
TGEM200	NULL
and	NULL
twice	NULL
with	NULL
TGEMSOO	NULL
(	NULL
TGEM200	NULL
with	NULL
the	NULL
concentration	NULL
of	NULL
NaC	NULL
]	NULL
increased	NULL
to	NULL
500	NULL
mM	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
pUl	NULL
glutathione	NULL
elution	NULL
buffer	NULL
(	NULL
80	NULL
mM	NULL
glutathione	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
5	NULL
mM	NULL
DTT	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
with	NULL
occasional	NULL
vortexing	NULL
.	NULL

The	NULL
supernatant	NULL
containing	NULL
eluted	NULL
GSTCITA	NULL
(	NULL
I-144	NULL
)	NULL
or	NULL
GSTCIHITA	NULL
(	NULL
1-144	NULL
)	NULL
A¥ah12	NULL
and	NULL
any	NULL
interacting	NULL
protein	NULL
was	NULL
collected	NULL
by	NULL
centrifugation	NULL
of	NULL
the	NULL
beads	NULL
.	NULL

The	NULL
eluates	NULL
were	NULL
divided	NULL
equally	NULL
and	NULL
run	NULL
on	NULL
two	NULL
SDS-PAGE	NULL
gels	NULL
,	NULL
followed	NULL
by	NULL
transfer	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Amersham	NULL
Inc.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
.	NULL
)	NULL

.	NULL

Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-	NULL
TAFpg32	NULL
anti-serum	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
anti-GST	NULL
anti-serum	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
full-length	NULL
wild-type	NULL
or	NULL
mutated	NULL
CITA	NULL
to	NULL
GST-TAFpq32	NULL
was	NULL
carried	NULL
out	NULL
identically	NULL
,	NULL
except	NULL
that	NULL
in	NULL
vitro	NULL
transcribed/translated	NULL
(	NULL
IVT	NULL
)	NULL
CHTA	NULL
or	NULL
mutant	NULL
CIITA	NULL
protein	NULL
was	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
instead	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
CIITA	NULL
proteins	NULL
were	NULL
produced	NULL
using	NULL
the	NULL
TnT	NULL
Coupled	NULL
In	NULL
Vitro	NULL
Transcription/Translation	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
with	NULL
5	NULL
uCi	NULL
[	NULL
S	NULL
Jmethionine	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

2524	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
A	NULL
N-terminal	NULL
Activation	NULL
Domain	NULL
of	NULL
CHTA	NULL
7B	NULL
CE	NULL
51	NULL
71	NULL
$	NULL
4	NULL
_	NULL
103	NULL
124	NULL
138	NULL
_	NULL
161	NULL
Amino	NULL
acid	NULL
:	NULL
1	NULL
B	NULL
%	NULL
Acidic	NULL
amino	NULL
acids	NULL
ahl	NULL
51-YDQMDLAGEEEIELYSEPDTD-71	NULL
40	NULL
%	NULL
ah2	NULL
84-DMEGDEETREAYAINELDQ-103	NULL
42	NULL
%	NULL
ab3	NULL
124-PDEVIGESMEMPAEV-138	NULL
33	NULL
%	NULL
Figure	NULL
1	NULL
.	NULL

Predicted	NULL
structure	NULL
and	NULL
acidic	NULL
amino	NULL
acid	NULL
content	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
N-terminal	NULL
161	NULL
amino	NULL
acids	NULL
of	NULL
CIITA	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

There	NULL
are	NULL
three	NULL
predicted	NULL
-helices	NULL
present	NULL
in	NULL
this	NULL
region	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
51-71	NULL
(	NULL
ah1	NULL
)	NULL
,	NULL
84-103	NULL
(	NULL
ah2	NULL
)	NULL
and	NULL
124-138	NULL
(	NULL
ah3	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
primary	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
three	NULL
present	NULL
in	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

Acidic	NULL
residues	NULL
(	NULL
glutamic	NULL
acid	NULL
and	NULL
aspartic	NULL
acid	NULL
)	NULL
are	NULL
in	NULL
bold	NULL
type	NULL
;	NULL
the	NULL
underlined	NULL
glycine	NULL
(	NULL
at	NULL
position	NULL
58	NULL
)	NULL
and	NULL
alanine	NULL
(	NULL
at	NULL
position	NULL
94	NULL
)	NULL
are	NULL
targets	NULL
for	NULL
point	NULL
mutation	NULL
to	NULL
proline	NULL
.	NULL

RESULTS	NULL
Prediction	NULL
of	NULL
the	NULL
secondary	NULL
structure	NULL
in	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
We	NULL
wanted	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
N-terminal	NULL
acidic	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
contained	NULL
any	NULL
predicted	NULL
secondary	NULL
structures	NULL
which	NULL
might	NULL
provide	NULL
insight	NULL
into	NULL
its	NULL
function	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
(	NULL
-helices	NULL
,	NULL
which	NULL
represent	NULL
functional	NULL
motifs	NULL
in	NULL
other	NULL
acidic	NULL
activators	NULL
(	NULL
23-25	NULL
)	NULL
,	NULL
could	NULL
provide	NULL
a	NULL
starting	NULL
point	NULL
for	NULL
mutagenesis	NULL
of	NULL
CIITA	NULL
.	NULL

The	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
CITA	NULL
was	NULL
analyzed	NULL
using	NULL
MacVector	NULL
computer	NULL
software	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
Chou-Fasman	NULL
and	NULL
Robson-Garnier	NULL
methods	NULL
were	NULL
employed	NULL
and	NULL
three	NULL
consensus	NULL
(	NULL
-helices	NULL
were	NULL
detected	NULL
,	NULL
which	NULL
we	NULL
labeled	NULL
ahl	NULL
(	NULL
amino	NULL
acids	NULL
51-71	NULL
)	NULL
ah2	NULL
(	NULL
amino	NULL
acids	NULL
84-103	NULL
)	NULL
and	NULL
ah3	NULL
(	NULL
amino	NULL
acids	NULL
124-138	NULL
;	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
each	NULL
of	NULL
these	NULL
-helices	NULL
demonstrated	NULL
that	NULL
they	NULL
were	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acid	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
analysis	NULL
,	NULL
these	NULL
three	NULL
acidic	NULL
-helices	NULL
were	NULL
chosen	NULL
as	NULL
the	NULL
focus	NULL
for	NULL
a	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

Mutation	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
,	NULL
but	NULL
not	NULL
ah3	NULL
,	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
by	NULL
CIITA	NULL
We	NULL
wanted	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
three	NULL
predicted	NULL
acidic	NULL
-helices	NULL
in	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
were	NULL
important	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
the	NULL
prototypic	NULL
class	NULL
II	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
three	NULL
(	NULL
-helices	NULL
was	NULL
deleted	NULL
from	NULL
full-length	NULL
CIITA	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
by	NULL
mutant	NULL
and	NULL
wild-type	NULL
CIITA	NULL
proteins	NULL
was	NULL
assayed	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
pDRASCAT	NULL
contains	NULL
the	NULL
DRA	NULL
promoter	NULL
from	NULL
position	NULL
-150	NULL
to	NULL
+31	NULL
linked	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
pSVCIITA	NULL
,	NULL
which	NULL
directs	NULL
expression	NULL
of	NULL
full-length	NULL
CIITA	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
,	NULL
with	NULL
pDRASCAT	NULL
resulted	NULL
in	NULL
levels	NULL
of	NULL
Plasmid	NULL
Target	NULL
;	NULL
pDRASCAT	NULL
Percent	NULL
wild-type	NULL
CHTA	NULL
activation	NULL
Plasmid	NULL
Effectors	NULL
:	NULL
CAT	NULL
Activity	NULL
pSVSPORT-I	NULL
pSVCNTA	NULL
pSVCHTAAN	NULL
pSVCIITAAahi	NULL
pSVCHTAAah2	NULL
pSVCHITAAah3	NULL
pSVCHITAAah12	NULL
pSVCIHITA	NULL
(	NULL
GSSP	NULL
)	NULL
pSVCIITA	NULL
(	NULL
GSEPAYP	NULL
)	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-N	NULL
)	NULL
pSVCITA	NULL
(	NULL
Aah2DE-NC	NULL
)	NULL
100.0	NULL
2.0	NULL
27.0	NULL
20.0	NULL
94.0	NULL
9.0	NULL
71.0	NULL
43.0	NULL
39.0	NULL
34.0	NULL
18.0	NULL
Figure	NULL
2	NULL
.	NULL

The	NULL
predicted	NULL
(	NULL
-helices	NULL
in	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
are	NULL
required	NULL
to	NULL
activate	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
pDRASCAT	NULL
(	NULL
0.25	NULL
ug	NULL
)	NULL
(	NULL
18	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
DRA	NULL
promoter	NULL
from	NULL
position	NULL
-150	NULL
to	NULL
+31	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
co-transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmid	NULL
effector	NULL
(	NULL
0.75	NULL
ug	NULL
)	NULL
into	NULL
HeLa	NULL
cells	NULL
.	NULL

pSVSPORT-1	NULL
is	NULL
the	NULL
parental	NULL
plasmid	NULL
effector	NULL
,	NULL
containing	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
and	NULL
bovine	NULL
growth	NULL
hormone	NULL
polyadenylation	NULL
sequence	NULL
.	NULL

pSVCIITA	NULL
contains	NULL
full-length	NULL
wild-type	NULL
CHTA	NULL
cDNA	NULL
(	NULL
from	NULL
nucleotide	NULL
position	NULL
+1	NULL
to	NULL
+3081	NULL
)	NULL
.	NULL

pSVCIITAAN	NULL
contains	NULL
the	NULL
CIITA	NULL
cDNA	NULL
from	NULL
nucleotide	NULL
position	NULL
+483	NULL
to	NULL
+3081	NULL
.	NULL

pSVCIITAAah1	NULL
,	NULL
ah1	NULL
deleted	NULL
;	NULL
pSVCIITAAah2	NULL
,	NULL
ah2	NULL
deleted	NULL
;	NULL
pSVCIITAAah3	NULL
,	NULL
ah3	NULL
deleted	NULL
;	NULL
pSVCHITAAgah12	NULL
,	NULL
ah1	NULL
and	NULL
ah2	NULL
deleted	NULL
;	NULL
pSVCIITA	NULL
(	NULL
GS8P	NULL
)	NULL
,	NULL
mutation	NULL
of	NULL
glycine	NULL
to	NULL
proline	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
58	NULL
;	NULL
mutation	NULL
of	NULL
alanine	NULL
to	NULL
proline	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
94	NULL
;	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-N	NULL
)	NULL
,	NULL
mutation	NULL
of	NULL
aspartic	NULL
acid	NULL
and	NULL
glutamic	NULL
acid	NULL
residues	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
84	NULL
and	NULL
86	NULL
respectively	NULL
;	NULL
pSVCHTA	NULL
(	NULL
Aah2DE-NC	NULL
)	NULL
,	NULL
the	NULL
same	NULL
mutations	NULL
as	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-N	NULL
)	NULL
with	NULL
additional	NULL
mutations	NULL
of	NULL
aspartic	NULL
acid	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
88	NULL
and	NULL
glutamic	NULL
acid	NULL
residues	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
89	NULL
and	NULL
90	NULL
;	NULL
S	NULL
,	NULL
S	NULL
box	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
;	NULL
X	NULL
,	NULL
X	NULL
box	NULL
;	NULL
X2	NULL
,	NULL
X2	NULL
box	NULL
;	NULL
Y	NULL
,	NULL
Y	NULL
box	NULL
;	NULL
O	NULL
,	NULL
octamer	NULL
binding	NULL
site	NULL
;	NULL
I	NULL
,	NULL
initiator	NULL
element	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
means	NULL
of	NULL
duplicate	NULL
transfections	NULL
+	NULL
SEM	NULL
.	NULL

expression	NULL
which	NULL
were	NULL
54-fold	NULL
greater	NULL
than	NULL
those	NULL
with	NULL
pDRASCAT	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
N-terminal	NULL
161	NULL
amino	NULL
acids	NULL
of	NULL
CITA	NULL
(	NULL
pSVCIITAAN	NULL
)	NULL
resulted	NULL
in	NULL
complete	NULL
loss	NULL
of	NULL
CHTA	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

When	NULL
ahl	NULL
(	NULL
pSVCIITAAah1	NULL
)	NULL
or	NULL
ah2	NULL
(	NULL
pSVCIHITAAgah	NULL
?	NULL

2	NULL
)	NULL
were	NULL
deleted	NULL
,	NULL
activation	NULL
of	NULL
pDRASCAT	NULL
was	NULL
reduced	NULL
.	NULL

pSVCIITAAah1	NULL
activated	NULL
pDRASCAT	NULL
14-fold	NULL
,	NULL
representing	NULL
27	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
CIITA	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
activity	NULL
with	NULL
pSVCIITAAah2	NULL
was	NULL
more	NULL
severe	NULL
.	NULL

Expression	NULL
of	NULL
pDRASCAT	NULL
was	NULL
reduced	NULL
to	NULL
20	NULL
%	NULL
of	NULL
that	NULL
with	NULL
wild-type	NULL
CIITA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
both	NULL
ah1	NULL
and	NULL
ah2	NULL
(	NULL
pSVCIITAAah12	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
essentially	NULL
non-functional	NULL
protein	NULL
which	NULL
activated	NULL
transcription	NULL
to	NULL
levels	NULL
only	NULL
9	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
CIITA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
removal	NULL
of	NULL
the	NULL
entire	NULL
activation	NULL
domain	NULL
of	NULL
CIHITA	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
-helix	NULL
(	NULL
ah3	NULL
)	NULL
was	NULL
not	NULL
detrimental	NULL
to	NULL
the	NULL
function	NULL
of	NULL
CHTA	NULL
.	NULL

pSVCIITAAah3	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
pDRASCAT	NULL
to	NULL
nearly	NULL
wild-type	NULL
levels	NULL
,	NULL
i.e	NULL
.	NULL

50-fold	NULL
.	NULL

To	NULL
test	NULL
the	NULL
structural	NULL
predictions	NULL
regarding	NULL
the	NULL
ahl	NULL
and	NULL
ah2	NULL
regions	NULL
,	NULL
proline	NULL
substitutions	NULL
were	NULL
made	NULL
in	NULL
the	NULL
center	NULL
of	NULL
each	NULL
of	NULL
the	NULL
two	NULL
active	NULL
(	NULL
-helices	NULL
,	NULL
alone	NULL
and	NULL
in	NULL
combination	NULL
.	NULL

Such	NULL
insertions	NULL
should	NULL
disrupt	NULL
formation	NULL
of	NULL
the	NULL
a-helix	NULL
.	NULL

in	NULL
which	NULL
the	NULL
glycine	NULL
residue	NULL
at	NULL
position	NULL
58	NULL
of	NULL
ahl	NULL
was	NULL
converted	NULL
to	NULL
proline	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
activated	NULL
pDRASCAT	NULL
38-fold	NULL
,	NULL
which	NULL
represented	NULL
71	NULL
%	NULL
of	NULL
the	NULL
activation	NULL
by	NULL
wild-type	NULL
CIITA	NULL
.	NULL

Disruption	NULL
of	NULL
ah2	NULL
by	NULL
mutation	NULL
of	NULL
alanine	NULL
at	NULL
position	NULL
94	NULL
to	NULL
proline	NULL
[	NULL
pSVCIITA	NULL
(	NULL
AY4P	NULL
)	NULL
]	NULL
had	NULL
a	NULL
more	NULL
severe	NULL
effect	NULL
on	NULL
CIITA	NULL
function	NULL
,	NULL
following	NULL
the	NULL
trend	NULL
of	NULL
the	NULL
larger	NULL
deletions	NULL
.	NULL

pSVCIITA	NULL
(	NULL
AAP	NULL
)	NULL
activated	NULL
pDRASCAT	NULL
at	NULL
levels	NULL
43	NULL
%	NULL
of	NULL
those	NULL
observed	NULL
with	NULL
wild-type	NULL
CIITA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

When	NULL
both	NULL
alanine	NULL
to	NULL
proline	NULL
mutations	NULL
are	NULL
present	NULL
in	NULL
CIHITA	NULL
[	NULL
pSVCIHITA	NULL
(	NULL
GS8PAQAP	NULL
)	NULL
]	NULL
,	NULL
activation	NULL
of	NULL
pDRASCAT	NULL
is	NULL
reduced	NULL
to	NULL
39	NULL
%	NULL
that	NULL
of	NULL
wild-type	NULL
CIITA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
ah1	NULL
and	NULL
ah2	NULL
are	NULL
critical	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
by	NULL
CITA	NULL
and	NULL
likely	NULL
represent	NULL
true	NULL
acidic	NULL
(	NULL
-helices	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
acidic	NULL
residues	NULL
present	NULL
in	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIHITA	NULL
are	NULL
indeed	NULL
required	NULL
to	NULL
activate	NULL
transcription	NULL
,	NULL
we	NULL
made	NULL
mutations	NULL
in	NULL
ah2	NULL
,	NULL
sequentially	NULL
reducing	NULL
the	NULL
number	NULL
of	NULL
acidic	NULL
residues	NULL
.	NULL

In	NULL
plasmid	NULL
pSVCIITA	NULL
(	NULL
Aah2DE-N	NULL
)	NULL
an	NULL
aspartic	NULL
acid	NULL
residue	NULL
at	NULL
position	NULL
84	NULL
and	NULL
a	NULL
glutamic	NULL
acid	NULL
residue	NULL
at	NULL
position	NULL
86	NULL
were	NULL
mutated	NULL
to	NULL
alanines	NULL
and	NULL
the	NULL
resulting	NULL
CITA	NULL
protein	NULL
assayed	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
pDRASCAT	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
these	NULL
two	NULL
acidic	NULL
residues	NULL
resulted	NULL
in	NULL
a	NULL
drop	NULL
in	NULL
activation	NULL
to	NULL
34	NULL
%	NULL
that	NULL
of	NULL
wild-type	NULL
CIHITA	NULL
.	NULL

Three	NULL
additional	NULL
acidic	NULL
amino	NULL
acids	NULL
were	NULL
then	NULL
mutated	NULL
to	NULL
alanine	NULL
(	NULL
aspartic	NULL
acid	NULL
at	NULL
position	NULL
88	NULL
and	NULL
two	NULL
glutamic	NULL
acids	NULL
at	NULL
positions	NULL
89	NULL
and	NULL
90	NULL
)	NULL
to	NULL
produce	NULL
plasmid	NULL
pSVCII-TA	NULL
(	NULL
Aah2DE-NC	NULL
)	NULL
.	NULL

This	NULL
further	NULL
reduction	NULL
in	NULL
net	NULL
negative	NULL
charge	NULL
resulted	NULL
in	NULL
a	NULL
severe	NULL
reduction	NULL
in	NULL
activation	NULL
,	NULL
to	NULL
18	NULL
%	NULL
of	NULL
wild-type	NULL
CIITA	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
five	NULL
of	NULL
eight	NULL
acidic	NULL
residues	NULL
in	NULL
ah2	NULL
[	NULL
plasmid	NULL
pSVCIHITA	NULL
(	NULL
Aah2DE-NC	NULL
)	NULL
]	NULL
resulted	NULL
in	NULL
a	NULL
CIITA	NULL
protein	NULL
which	NULL
activated	NULL
transcription	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
when	NULL
the	NULL
entire	NULL
ah2	NULL
region	NULL
was	NULL
deleted	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
acidic	NULL
nature	NULL
of	NULL
the	NULL
ah2	NULL
region	NULL
is	NULL
indispensable	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Deletion	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
specifically	NULL
affect	NULL
function	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
The	NULL
reduction	NULL
in	NULL
activity	NULL
of	NULL
CIITA	NULL
proteins	NULL
bearing	NULL
the	NULL
deletion	NULL
of	NULL
ah	NULL
1	NULL
and	NULL
ah2	NULL
could	NULL
be	NULL
due	NULL
to	NULL
unrelated	NULL
structural	NULL
changes	NULL
in	NULL
the	NULL
protein	NULL
,	NULL
rather	NULL
than	NULL
to	NULL
specific	NULL
alterations	NULL
in	NULL
function	NULL
of	NULL
its	NULL
activation	NULL
domain	NULL
,	NULL
even	NULL
though	NULL
CIITA	NULL
protein	NULL
expression	NULL
levels	NULL
were	NULL
equivalent	NULL
(	NULL
data	NULL
not	NULL
presented	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
deletion	NULL
of	NULL
only	NULL
24	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
CIITA	NULL
produced	NULL
a	NULL
completely	NULL
non-functional	NULL
protein	NULL
in	NULL
the	NULL
BLSII	NULL
cell	NULL
line	NULL
BLS2	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Since	NULL
such	NULL
small	NULL
deletions	NULL
can	NULL
affect	NULL
function	NULL
or	NULL
stability	NULL
of	NULL
the	NULL
entire	NULL
protein	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
test	NULL
integrity	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
independently	NULL
of	NULL
full-length	NULL
CHTA	NULL
.	NULL

Therefore	NULL
,	NULL
fusion	NULL
proteins	NULL
between	NULL
the	NULL
147	NULL
amino	NULL
acid	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Gal4	NULL
and	NULL
the	NULL
region	NULL
of	NULL
CIITA	NULL
containing	NULL
the	NULL
three	NULL
o-helices	NULL
(	NULL
the	NULL
'three	NULL
o-helix	NULL
region	NULL
'	NULL
)	NULL
from	NULL
wild-type	NULL
and	NULL
mutated	NULL
CIITA	NULL
were	NULL
constructed	NULL
.	NULL

The	NULL
plasmid	NULL
effector	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
cDNA	NULL
coding	NULL
for	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
44	NULL
to	NULL
143	NULL
of	NULL
CITA	NULL
next	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Gal4	NULL
.	NULL

Following	NULL
their	NULL
co-transfection	NULL
into	NULL
COS	NULL
cells	NULL
,	NULL
pGalA4C	NULL
(	NULL
44-143	NULL
)	NULL
activated	NULL
the	NULL
plasmid	NULL
target	NULL
pGSbCAT	NULL
,	NULL
which	NULL
contains	NULL
five	NULL
Gal4	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
,	NULL
58-fold	NULL
greater	NULL
than	NULL
the	NULL
parental	NULL
vector	NULL
pSG424	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
ahl	NULL
from	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
,	NULL
to	NULL
produce	NULL
pGal4CAah1	NULL
,	NULL
activated	NULL
pGSbCAT	NULL
only	NULL
14-fold	NULL
over	NULL
baseline	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
level	NULL
of	NULL
expression	NULL
represents	NULL
24	NULL
%	NULL
of	NULL
the	NULL
activation	NULL
observed	NULL
with	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
.	NULL

ah2	NULL
,	NULL
which	NULL
was	NULL
deleted	NULL
in	NULL
pGal4CAah2	NULL
,	NULL
proved	NULL
again	NULL
to	NULL
be	NULL
the	NULL
more	NULL
active	NULL
(	NULL
-helix	NULL
.	NULL

Activation	NULL
with	NULL
pGal4CAah2	NULL
was	NULL
10-fold	NULL
greater	NULL
than	NULL
baseline	NULL
levels	NULL
,	NULL
representing	NULL
only	NULL
16	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
double	NULL
mutation	NULL
pGal4CAah12	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
-	NULL
2525	NULL
Plasmid	NULL
Target	NULL
:	NULL
pGSEIbCAT	NULL
[	NULL
uase	NULL
]	NULL
[	NULL
base	NULL
]	NULL
[	NULL
vase	NULL
]	NULL
[	NULL
uase	NULL
]	NULL
{	NULL
uase	NULL
}	NULL
-*	NULL
``	NULL
*-~A-	NULL
(	NULL
Cat	NULL
GA	NULL
)	NULL
Percent	NULL
wild-type	NULL
Plasmid	NULL
Effectors	NULL
:	NULL
CAT	NULL
Activity	NULL
CHTA	NULL
activation	NULL
pSG424	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
100.0	NULL
pGal4CAah1	NULL
24.0	NULL
16.0	NULL
pGaMCAah3	NULL
125.0	NULL
pGal4CAah12	NULL
3.0	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
600	NULL
Figure	NULL
3	NULL
.	NULL

Deletions	NULL
of	NULL
predicted	NULL
(	NULL
-helices	NULL
in	NULL
the	NULL
N-terminus	NULL
of	NULL
CITA	NULL
specifically	NULL
effect	NULL
function	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
pGSbCAT	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
(	NULL
1	NULL
)	NULL
,	NULL
containing	NULL
five	NULL
Gal4	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
from	NULL
the	NULL
adenovirus	NULL
E1	NULL
gene	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
was	NULL
co-transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmid	NULL
effector	NULL
(	NULL
1.5	NULL
ug	NULL
)	NULL
into	NULL
COS	NULL
cells	NULL
.	NULL

The	NULL
parental	NULL
plasmid	NULL
effector	NULL
,	NULL
pSG424	NULL
(	NULL
17	NULL
)	NULL
,	NULL
expressed	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

The	NULL
remaining	NULL
plasmid	NULL
effectors	NULL
express	NULL
wild-type	NULL
or	NULL
¢-helix-deleted	NULL
CIITA	NULL
from	NULL
amino	NULL
acid	NULL
position	NULL
44	NULL
to	NULL
143	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
,	NULL
wild-type	NULL
CHTA	NULL
;	NULL
pGal4CAgh1	NULL
,	NULL
ah1	NULL
deleted	NULL
;	NULL
pGal4CAah2	NULL
,	NULL
ah2	NULL
deleted	NULL
;	NULL
pGal4CAah3	NULL
,	NULL
ah3	NULL
deleted	NULL
;	NULL
pGal4CAah12	NULL
,	NULL
both	NULL
ah1	NULL
and	NULL
ah2	NULL
deleted	NULL
;	NULL
UASg	NULL
,	NULL
Gal4	NULL
binding	NULL
site	NULL
;	NULL
TATA	NULL
,	NULL
TATA	NULL
box	NULL
;	NULL
pA	NULL
,	NULL
polyadenylation	NULL
sequence	NULL
;	NULL
GDB	NULL
,	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
means	NULL
of	NULL
duplicate	NULL
transfections	NULL
+	NULL
SEM	NULL
.	NULL

was	NULL
non-functional	NULL
and	NULL
activated	NULL
transcription	NULL
only	NULL
2-fold	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
deletion	NULL
of	NULL
ah3	NULL
produced	NULL
slightly	NULL
increased	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

pGal4CAah3	NULL
increased	NULL
expression	NULL
from	NULL
pGSbCAT	NULL
73-fold	NULL
,	NULL
to	NULL
levels	NULL
which	NULL
were	NULL
125	NULL
%	NULL
of	NULL
those	NULL
observed	NULL
with	NULL
pGal4C	NULL
(	NULL
44-143	NULL
)	NULL
.	NULL

This	NULL
result	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
increased	NULL
accessibility	NULL
of	NULL
ahl	NULL
and	NULL
ah2	NULL
to	NULL
the	NULL
general	NULL
transcriptional	NULL
apparatus	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
three	NULL
o-helix	NULL
region	NULL
,	NULL
comprising	NULL
amino	NULL
acids	NULL
from	NULL
position	NULL
44	NULL
to	NULL
143	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
CIITA	NULL
and	NULL
that	NULL
ahl	NULL
and	NULL
ah2	NULL
are	NULL
required	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

CIITAAah12	NULL
represents	NULL
a	NULL
dominant	NULL
negative	NULL
CIITA	NULL
The	NULL
ah	NULL
deletions	NULL
in	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
are	NULL
not	NULL
likely	NULL
to	NULL
effect	NULL
function	NULL
of	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Since	NULL
the	NULL
C-terminal	NULL
830	NULL
amino	NULL
acids	NULL
of	NULL
CIITA	NULL
are	NULL
sufficient	NULL
to	NULL
direct	NULL
the	NULL
protein	NULL
to	NULL
the	NULL
DRA	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
CIHITAAah12	NULL
mutant	NULL
still	NULL
interacts	NULL
at	NULL
the	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
since	NULL
CIHITAAah12	NULL
can	NULL
not	NULL
activate	NULL
transcription	NULL
,	NULL
it	NULL
might	NULL
function	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
CIITA	NULL
protein	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
pSVCIHITA	NULL
was	NULL
co-transfected	NULL
with	NULL
pDRASCAT	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
pSVCIHITAAah12	NULL
into	NULL
COS	NULL
cells	NULL
.	NULL

Co-transfection	NULL
of	NULL
pDRASCAT	NULL
with	NULL
pSVCIITA	NULL
resulted	NULL
in	NULL
levels	NULL
of	NULL
expression	NULL
17-fold	NULL
greater	NULL
than	NULL
with	NULL
pDRASCAT	NULL
alone	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

Addition	NULL
of	NULL
pSVCIITAAah12	NULL
at	NULL
a	NULL
2:1	NULL
ratio	NULL
to	NULL
pSVCIITA	NULL
resulted	NULL
in	NULL
an	NULL
~50	NULL
%	NULL
reduction	NULL
of	NULL
expression	NULL
from	NULL
pDRASCAT	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

At	NULL
a	NULL
ratio	NULL
of	NULL
8:1	NULL
,	NULL
expression	NULL
fell	NULL
further	NULL
,	NULL
to	NULL
30	NULL
%	NULL
of	NULL
levels	NULL
observed	NULL
with	NULL
pSVCIITA	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
2526	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Fraction	NULL
of	NULL
activation	NULL
by	NULL
CAT	NULL
Activity	NULL
pSVCIITA	NULL
alone	NULL
Plasmid	NULL
Effectors	NULL
:	NULL
pSVSPORT-1	NULL
pSVCHITA	NULL
1.0	NULL
0.49	NULL
0.30	NULL
pSVCHTAAah12	NULL
[	NULL
2:1	NULL
+	NULL
8:1	NULL
pSVCNTA	NULL
1.80	NULL
8:1	NULL
4.00	NULL
pSVCITAAah3	NULL
|	NULL
al	NULL
+	NULL
pSVCHITA	NULL
0	NULL
-	NULL
200	NULL
400	NULL
600	NULL
800	NULL
1000	NULL
1200	NULL
Figure	NULL
4	NULL
.	NULL

CHTAAah12	NULL
functions	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
repressor	NULL
of	NULL
wild-type	NULL
CIITA	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
pDRASCAT	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
was	NULL
co-transfected	NULL
with	NULL
pSVCHITA	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
alone	NULL
or	NULL
with	NULL
pSVCIITAAah12	NULL
or	NULL
pSVCIITAAah3	NULL
(	NULL
0.2	NULL
or	NULL
0.8	NULL
ug	NULL
)	NULL
into	NULL
COS	NULL
cells	NULL
.	NULL

Appropriate	NULL
amounts	NULL
of	NULL
pSVSPORT-1	NULL
were	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
to	NULL
keep	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
at	NULL
2	NULL
ug	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
means	NULL
of	NULL
duplicate	NULL
transfections	NULL
+	NULL
SEM	NULL
.	NULL

contrast	NULL
,	NULL
addition	NULL
of	NULL
pSVCIITAAah3	NULL
increased	NULL
levels	NULL
of	NULL
expression	NULL
from	NULL
pDRASCAT	NULL
.	NULL

Levels	NULL
increased	NULL
1.8-	NULL
and	NULL
4.0-fold	NULL
when	NULL
pSVCIITAAah3	NULL
was	NULL
included	NULL
in	NULL
the	NULL
transfection	NULL
at	NULL
ratios	NULL
of	NULL
2:1	NULL
and	NULL
8:1	NULL
respectively	NULL
with	NULL
pSVCIITA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
deletion	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
from	NULL
CIITA	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
but	NULL
rather	NULL
only	NULL
effects	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

ah1	NULL
and	NULL
ab2	NULL
are	NULL
required	NULL
for	NULL
full	NULL
interaction	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
with	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
TAFp32	NULL
Transcriptional	NULL
activation	NULL
by	NULL
acidic	NULL
activators	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
components	NULL
of	NULL
the	NULL
general	NULL
transcriptional	NULL
machinery	NULL
.	NULL

VP16	NULL
,	NULL
for	NULL
example	NULL
,	NULL
binds	NULL
to	NULL
several	NULL
general	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
32	NULL
kDa	NULL
subunit	NULL
of	NULL
the	NULL
human	NULL
TATA	NULL
binding	NULL
complex	NULL
TFIID	NULL
,	NULL
TAFg32	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Given	NULL
its	NULL
functional	NULL
homology	NULL
to	NULL
VP16	NULL
(	NULL
16	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
CHTA	NULL
might	NULL
also	NULL
bind	NULL
to	NULL
TFIID	NULL
via	NULL
the	NULL
TAFpg32	NULL
subunit	NULL
and	NULL
whether	NULL
ah	NULL
1	NULL
and	NULL
ah2	NULL
are	NULL
important	NULL
for	NULL
this	NULL
interaction	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
CIITA	NULL
proteins	NULL
fused	NULL
to	NULL
GST	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proteins	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
using	NULL
an	NULL
anti-TAFpg32	NULL
antiserum	NULL
.	NULL

Two	NULL
prokaryotic	NULL
expression	NULL
plasmids	NULL
were	NULL
constructed	NULL
to	NULL
express	NULL
GST	NULL
fusion	NULL
proteins	NULL
in	NULL
E.coli	NULL
.	NULL

GSTCHTA	NULL
(	NULL
I-144	NULL
)	NULL
contained	NULL
the	NULL
first	NULL
144	NULL
amino	NULL
acids	NULL
of	NULL
CHTA	NULL
,	NULL
which	NULL
included	NULL
the	NULL
three	NULL
-helix	NULL
region	NULL
.	NULL

The	NULL
second	NULL
fusion	NULL
protein	NULL
was	NULL
similar	NULL
,	NULL
except	NULL
that	NULL
ah1	NULL
and	NULL
ah2	NULL
were	NULL
deleted	NULL
to	NULL
produce	NULL
GSTCIITA	NULL
(	NULL
1-144	NULL
)	NULL
Aah12	NULL
.	NULL

The	NULL
chimeras	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
then	NULL
purified	NULL
using	NULL
glutathione	NULL
Sepharose	NULL
beads	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
,	NULL
the	NULL
GSTCIITA	NULL
fusion	NULL
proteins	NULL
and	NULL
any	NULL
interacting	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
beads	NULL
using	NULL
glutathione	NULL
and	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

Western	NULL
blotting	NULL
with	NULL
the	NULL
anti-TAFp32	NULL
antiserum	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
TAFpg32	NULL
bound	NULL
to	NULL
either	NULL
of	NULL
these	NULL
two	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
32	NULL
kDa	NULL
TAFpg32	NULL
protein	NULL
was	NULL
easily	NULL
detected	NULL
in	NULL
unfractionated	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

TAFp32	NULL
was	NULL
not	NULL
detected	NULL
when	NULL
the	NULL
chimera	NULL
deleted	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
[	NULL
GSTCIHITA	NULL
(	NULL
1-144	NULL
)	NULL
A¥ah12	NULL
]	NULL
was	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TAFpg32	NULL
was	NULL
present	NULL
in	NULL
the	NULL
eluate	NULL
from	NULL
the	NULL
binding	NULL
reaction	NULL
containing	NULL
GSTCITA	NULL
(	NULL
I-144	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Probing	NULL
identical	NULL
blots	NULL
with	NULL
an	NULL
anti-GST	NULL
antiserum	NULL
demonstrated	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
the	NULL
1	NULL
2	NULL
3	NULL
TAFj32	NULL
>	NULL
|	NULL
wi	NULL
wer	NULL
4	NULL
5	NULL
6	NULL
GSTCHTA	NULL
(	NULL
1-143	NULL
)	NULL
>	NULL
GSTCHIA	NULL
(	NULL
I-143	NULL
)	NULL
Aah12	NULL
>	NULL
--	NULL
==	NULL
=	NULL
Figure	NULL
5.	NULL
ah1	NULL
and	NULL
ah2	NULL
are	NULL
required	NULL
for	NULL
interaction	NULL
of	NULL
CIITA	NULL
with	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
TAFpg32	NULL
.	NULL

Fusion	NULL
proteins	NULL
between	NULL
GST	NULL
and	NULL
wild-type	NULL
[	NULL
GSTCHITA	NULL
(	NULL
I-144	NULL
)	NULL
]	NULL
or	NULL
ah1	NULL
and	NULL
ah2	NULL
deleted	NULL
[	NULL
GSTCHITA	NULL
(	NULL
1-144	NULL
)	NULL
Aah12	NULL
]	NULL
CHTA	NULL
from	NULL
amino	NULL
acid	NULL
position	NULL
1	NULL
to	NULL
144	NULL
were	NULL
expressed	NULL
in	NULL
E.coli	NULL
and	NULL
purified	NULL
on	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

Glutathione	NULL
eluates	NULL
from	NULL
binding	NULL
reactions	NULL
between	NULL
GSTCHITA	NULL
(	NULL
I-144	NULL
)	NULL
or	NULL
GSTCIITA	NULL
(	NULL
I-144	NULL
)	NULL
¥ah12	NULL
and	NULL
B	NULL
cell	NULL
nuclear	NULL
extract	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
Western	NULL
transfer	NULL
and	NULL
immunodetection	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
Western	NULL
blot	NULL
with	NULL
anti-TAFp32	NULL
antiserum	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
detection	NULL
of	NULL
TAFp32	NULL
in	NULL
unfractionated	NULL
B	NULL
cell	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
no	NULL
TAFg32	NULL
was	NULL
present	NULL
in	NULL
eluate	NULL
from	NULL
the	NULL
GSTCHITA	NULL
(	NULL
I-144	NULL
)	NULL
¥ah12	NULL
binding	NULL
reaction	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
detection	NULL
of	NULL
TAFp32	NULL
in	NULL
eluate	NULL
from	NULL
the	NULL
GSTCIITA	NULL
(	NULL
1-144	NULL
)	NULL
binding	NULL
reaction	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Western	NULL
blot	NULL
with	NULL
anti-GST	NULL
antiserum	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
GSTCHITA	NULL
(	NULL
I-144	NULL
)	NULL
Aah12	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
GSTCHTA	NULL
(	NULL
1-144	NULL
)	NULL
.	NULL

Additional	NULL
bands	NULL
present	NULL
in	NULL
lane	NULL
5	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
degradation	NULL
products	NULL
of	NULL
GSTCIHITA	NULL
(	NULL
1-144	NULL
)	NULL
ah12	NULL
.	NULL

GST-CIITA	NULL
fusion	NULL
proteins	NULL
were	NULL
present	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

From	NULL
these	NULL
results	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
first	NULL
144	NULL
amino	NULL
acids	NULL
of	NULL
CHTA	NULL
can	NULL
interact	NULL
with	NULL
TAFg32	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
ah1	NULL
and	NULL
ah2	NULL
.	NULL

Since	NULL
ah1	NULL
and	NULL
ah2	NULL
are	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
CIITA	NULL
,	NULL
this	NULL
result	NULL
implies	NULL
that	NULL
binding	NULL
of	NULL
TAFg32	NULL
is	NULL
required	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

Binding	NULL
ability	NULL
of	NULL
CIHITA	NULL
and	NULL
CIITA	NULL
mutants	NULL
to	NULL
TAFp32	NULL
corresponds	NULL
with	NULL
transcriptional	NULL
activation	NULL
We	NULL
demonstrated	NULL
above	NULL
that	NULL
the	NULL
first	NULL
144	NULL
amino	NULL
acids	NULL
of	NULL
CHITA	NULL
,	NULL
which	NULL
contain	NULL
the	NULL
three	NULL
o-helix	NULL
region	NULL
,	NULL
interact	NULL
with	NULL
TAFg32	NULL
.	NULL

We	NULL
therefore	NULL
wanted	NULL
to	NULL
try	NULL
to	NULL
coordinate	NULL
the	NULL
ability	NULL
of	NULL
CHTA	NULL
and	NULL
mutations	NULL
of	NULL
CIITA	NULL
to	NULL
bind	NULL
to	NULL
TAFpq32	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
GST-TAFg32	NULL
fusion	NULL
protein	NULL
and	NULL
wild-type	NULL
and	NULL
mutant	NULL
CIITA	NULL
proteins	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
of	NULL
CIITA	NULL
expression	NULL
plasmids	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
elutions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
Figure	NULL
5	NULL
and	NULL
eluates	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
of	NULL
the	NULL
[	NULL
°SJmethionine-labeled	NULL
CITA	NULL
.	NULL

Full-length	NULL
wild-type	NULL
CHTA	NULL
and	NULL
CIITAAah3	NULL
bound	NULL
to	NULL
GST-TAFp32	NULL
equivalently	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
respectively	NULL
)	NULL
.	NULL

This	NULL
result	NULL
implies	NULL
that	NULL
fully	NULL
functional	NULL
CIITA	NULL
proteins	NULL
interact	NULL
well	NULL
with	NULL
TAFg32	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CHTAAah1	NULL
and	NULL
CIHITAAah2	NULL
bound	NULL
to	NULL
TAFpg32	NULL
very	NULL
poorly	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
respectively	NULL
)	NULL
,	NULL
with	NULL
CIHITAAah1	NULL
binding	NULL
slightly	NULL
more	NULL
than	NULL
CHITAAah2	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
co-transfection	NULL
experiments	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

With	NULL
the	NULL
double	NULL
mutation	NULL
CHIHTAAah12	NULL
there	NULL
was	NULL
almost	NULL
no	NULL
detectable	NULL
binding	NULL
to	NULL
TAFp32	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

One	NULL
tenth	NULL
of	NULL
the	NULL
input	NULL
volume	NULL
of	NULL
in	NULL
vitro	NULL
transcribed/translated	NULL
CIITA	NULL
proteins	NULL
were	NULL
run	NULL
on	NULL
an	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
autoradiographed	NULL
,	NULL
to	NULL
demonstrate	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
€	NULL
TE	NULL
‘	NULL
S	NULL
‘	NULL
C	NULL
:	NULL
#	NULL
0	NULL
'	NULL
f	NULL
do	NULL
@	NULL
4	NULL
4	NULL
4	NULL
4	NULL
<	NULL
o	NULL
&	NULL
@	NULL
d	NULL
<	NULL
2	NULL
E	NULL
E	NULL
E	NULL
R	NULL
G	NULL
0	NULL
8	NULL
5	NULL
5	NULL
GSTTAFp32	NULL
[	NULL
*+	NULL
pull-down	NULL
bn	NULL
?	NULL

ﬂ	NULL
.	NULL

6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Figure	NULL
6	NULL
.	NULL

Binding	NULL
of	NULL
CIITA	NULL
to	NULL
the	NULL
TBP-associated	NULL
factor	NULL
TAFg32	NULL
requires	NULL
both	NULL
ah1	NULL
and	NULL
ah2	NULL
.	NULL

A	NULL
fusion	NULL
protein	NULL
between	NULL
GST	NULL
and	NULL
human	NULL
TAFpg32	NULL
was	NULL
expressed	NULL
in	NULL
E.coli	NULL
and	NULL
purified	NULL
on	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

GST-TAFp32	NULL
was	NULL
incubated	NULL
with	NULL
wild-type	NULL
or	NULL
mutated	NULL
full-length	NULL
CIITA	NULL
proteins	NULL
,	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
P°S	NULL
)	NULL
methionine	NULL
.	NULL

Eluates	NULL
from	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
of	NULL
the	NULL
CIITA	NULL
proteins	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
Autoradiograph	NULL
of	NULL
eluates	NULL
from	NULL
the	NULL
GST-TAFpg32	NULL
binding	NULL
reaction	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild-type	NULL
CIITA	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
CIITAAah1	NULL
,	NULL
deletion	NULL
of	NULL
ah1	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
CHITAAah2	NULL
,	NULL
deletion	NULL
of	NULL
ah2	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
CHITAAah3	NULL
,	NULL
deletion	NULL
of	NULL
ah3	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
CHITAAah12	NULL
,	NULL
deletion	NULL
of	NULL
ahl	NULL
and	NULL
ah2	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
One	NULL
tenth	NULL
the	NULL
input	NULL
volume	NULL
of	NULL
CIITA	NULL
proteins	NULL
from	NULL
the	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
reaction	NULL
.	NULL

Lane	NULL
6	NULL
,	NULL
wild-type	NULL
CIITA	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
CHITAAah1	NULL
,	NULL
deletion	NULL
of	NULL
ah1	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
CHITAAah2	NULL
,	NULL
deletion	NULL
of	NULL
ah2	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
CIITAAah3	NULL
,	NULL
deletion	NULL
of	NULL
ah3	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
CHTAAah12	NULL
,	NULL
deletion	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
.	NULL

protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
binding	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
binding	NULL
profiles	NULL
of	NULL
mutant	NULL
CIITA	NULL
proteins	NULL
to	NULL
GST-TAFp32	NULL
corresponded	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
CIITA	NULL
and	NULL
TAFpg32	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activity	NULL
of	NULL
CIITA	NULL
.	NULL

DISCUSSION	NULL
The	NULL
N-terminal	NULL
125	NULL
amino	NULL
acids	NULL
of	NULL
CITA	NULL
have	NULL
been	NULL
defined	NULL
as	NULL
an	NULL
independent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Computer	NULL
analyses	NULL
of	NULL
the	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
CIITA	NULL
activation	NULL
domain	NULL
predicted	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
a-helices	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
.	NULL

ahl	NULL
and	NULL
ah2	NULL
,	NULL
the	NULL
N-terminal	NULL
and	NULL
middle	NULL
acidic	NULL
(	NULL
-helices	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
required	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
DRA	NULL
promoter	NULL
.	NULL

Deletion	NULL
of	NULL
ah1	NULL
and	NULL
ah2	NULL
or	NULL
amino	NULL
acid	NULL
substitutions	NULL
which	NULL
disrupted	NULL
formation	NULL
of	NULL
the	NULL
a-helices	NULL
resulted	NULL
in	NULL
a	NULL
severe	NULL
reduction	NULL
in	NULL
function	NULL
of	NULL
the	NULL
mutant	NULL
CIITA	NULL
proteins	NULL
.	NULL

Similarly	NULL
,	NULL
sequential	NULL
reduction	NULL
in	NULL
net	NULL
negative	NULL
charge	NULL
of	NULL
ah2	NULL
resulted	NULL
in	NULL
concurrent	NULL
reduction	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
mutated	NULL
CIITA	NULL
proteins	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
C-terminal	NULL
-helix	NULL
,	NULL
ah3	NULL
,	NULL
was	NULL
not	NULL
detrimental	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
CIITA	NULL
.	NULL

Mutations	NULL
which	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
transactivation	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
by	NULL
CIITA	NULL
also	NULL
resulted	NULL
in	NULL
proportional	NULL
loss	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
32	NULL
kDa	NULL
subunit	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
complex	NULL
TFIID	NULL
,	NULL
TAFpg32	NULL
.	NULL

From	NULL
these	NULL
data	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
functional	NULL
motifs	NULL
in	NULL
the	NULL
CIITA	NULL
activation	NULL
domain	NULL
are	NULL
the	NULL
acidic	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
-	NULL
2527	NULL
CHTA	NULL
ACTIVATES	NULL
TRANSCRIPTION	NULL
VIA	NULL
TAFpp32	NULL
CLASS	NULL
II	NULL
PROMOTER	NULL
Figure	NULL
7	NULL
.	NULL

Protein-DNA	NULL
and	NULL
protein-protein	NULL
interactions	NULL
on	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

NFY	NULL
and	NULL
RFX	NULL
bind	NULL
to	NULL
conserved	NULL
upstream	NULL
sequences	NULL
(	NULL
S	NULL
,	NULL
X	NULL
and	NULL
Y	NULL
boxes	NULL
)	NULL
of	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

NFY	NULL
stabilizes	NULL
binding	NULL
of	NULL
RFX	NULL
to	NULL
the	NULL
X	NULL
box	NULL
and	NULL
might	NULL
contribute	NULL
to	NULL
interactions	NULL
with	NULL
CIITA	NULL
.	NULL

Cooperative	NULL
binding	NULL
occurs	NULL
between	NULL
RFX	NULL
complexes	NULL
bound	NULL
at	NULL
the	NULL
S	NULL
and	NULL
X	NULL
boxes	NULL
.	NULL

Although	NULL
CIITA	NULL
requires	NULL
minimally	NULL
the	NULL
X	NULL
box	NULL
,	NULL
no	NULL
direct	NULL
binding	NULL
between	NULL
RFX	NULL
and	NULL
CITA	NULL
has	NULL
been	NULL
demonstrated	NULL
.	NULL

The	NULL
B	NULL
cell-specific	NULL
co-activator	NULL
Bob1	NULL
(	NULL
OBF-1/0CA-B	NULL
)	NULL
interacts	NULL
directly	NULL
with	NULL
CIITA	NULL
,	NULL
to	NULL
increase	NULL
transcription	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
interacts	NULL
with	NULL
TAFIIM32	NULL
,	NULL
which	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
TAF-TBP	NULL
complex	NULL
(	NULL
TFIID	NULL
)	NULL
.	NULL

These	NULL
protein-protein	NULL
interactions	NULL
increase	NULL
rates	NULL
of	NULL
initiation	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
.	NULL

(	NULL
-helices	NULL
ahl	NULL
and	NULL
ah2	NULL
and	NULL
that	NULL
interaction	NULL
between	NULL
these	NULL
-helices	NULL
and	NULL
TAFpg32	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
CHITA	NULL
.	NULL

CITA	NULL
is	NULL
an	NULL
acidic	NULL
transcriptional	NULL
activator	NULL
.	NULL

This	NULL
group	NULL
of	NULL
activators	NULL
were	NULL
first	NULL
defined	NULL
based	NULL
on	NULL
studies	NULL
with	NULL
the	NULL
yeast	NULL
proteins	NULL
GALA	NULL
and	NULL
GCN4	NULL
(	NULL
16,26	NULL
)	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
correlated	NULL
generally	NULL
with	NULL
the	NULL
net	NULL
negative	NULL
charge	NULL
of	NULL
the	NULL
acidic	NULL
domain	NULL
(	NULL
16,26	NULL
)	NULL
.	NULL

Additional	NULL
studies	NULL
using	NULL
random	NULL
genomic	NULL
DNA	NULL
from	NULL
E.coli	NULL
(	NULL
27	NULL
)	NULL
and	NULL
artificially	NULL
constructed	NULL
sequences	NULL
(	NULL
25	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
acidic	NULL
amphipathic	NULL
(	NULL
-helix	NULL
correlated	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
that	NULL
sequence	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Subsequent	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
found	NULL
that	NULL
the	NULL
C-terminal	NULL
activation	NULL
motif	NULL
of	NULL
GALA	NULL
may	NULL
not	NULL
contain	NULL
(	NULL
-helices	NULL
and	NULL
that	NULL
acidic	NULL
residues	NULL
were	NULL
not	NULL
critical	NULL
for	NULL
activator	NULL
function	NULL
(	NULL
28,29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
what	NULL
we	NULL
have	NULL
determined	NULL
for	NULL
CIHITA	NULL
,	NULL
disruption	NULL
of	NULL
potential	NULL
(	NULL
-helices	NULL
in	NULL
VP16	NULL
by	NULL
insertion	NULL
of	NULL
proline	NULL
residues	NULL
did	NULL
not	NULL
affect	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
has	NULL
identified	NULL
a	NULL
functional	NULL
acidic	NULL
-helix	NULL
(	NULL
24	NULL
)	NULL
similar	NULL
to	NULL
what	NULL
we	NULL
have	NULL
found	NULL
with	NULL
CHITA	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
requirement	NULL
of	NULL
net	NULL
negative	NULL
charge	NULL
has	NULL
been	NULL
firmly	NULL
established	NULL
for	NULL
many	NULL
activators	NULL
(	NULL
31-34	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
presence	NULL
of	NULL
bulky	NULL
hydrophobic	NULL
residues	NULL
which	NULL
are	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
35-37	NULL
)	NULL
.	NULL

We	NULL
have	NULL
presented	NULL
here	NULL
strong	NULL
evidence	NULL
that	NULL
CIITA	NULL
contains	NULL
functional	NULL
acidic	NULL
(	NULL
-helices	NULL
which	NULL
are	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

To	NULL
activate	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
assembly	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
must	NULL
first	NULL
occur	NULL
at	NULL
the	NULL
three	NULL
conserved	NULL
upstream	NULL
sequences	NULL
(	NULL
CUS	NULL
)	NULL
present	NULL
in	NULL
all	NULL
class	NULL
II	NULL
promoters	NULL
,	NULL
the	NULL
S	NULL
,	NULL
X	NULL
and	NULL
Y	NULL
boxes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Following	NULL
cooperative	NULL
binding	NULL
of	NULL
factors	NULL
to	NULL
these	NULL
elements	NULL
(	NULL
38-41	NULL
)	NULL
,	NULL
CIITA	NULL
makes	NULL
three	NULL
important	NULL
protein-protein	NULL
contacts	NULL
.	NULL

The	NULL
first	NULL
is	NULL
with	NULL
the	NULL
complexes	NULL
bound	NULL
at	NULL
the	NULL
S	NULL
,	NULL
X	NULL
and	NULL
Y	NULL
boxes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
these	NULL
contacts	NULL
is	NULL
unknown	NULL
.	NULL

Repeated	NULL
attempts	NULL
to	NULL
demonstrate	NULL
direct	NULL
binding	NULL
between	NULL
CIITA	NULL
and	NULL
the	NULL
X	NULL
box	NULL
binding	NULL
complex	NULL
RFX	NULL
(	NULL
42	NULL
)	NULL
have	NULL
been	NULL
unsuccessful	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Zhou	NULL
et	NULL
a/	NULL
.	NULL

have	NULL
presented	NULL
evidence	NULL
that	NULL
the	NULL
C-terminal	NULL
830	NULL
amino	NULL
acids	NULL
of	NULL
CITA	NULL
are	NULL
2528	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1997	NULL
,	NULL
Vol	NULL
.	NULL

25	NULL
,	NULL
No	NULL
.	NULL

12	NULL
sufficient	NULL
to	NULL
target	NULL
CIITA	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
.	NULL

That	NULL
the	NULL
mutant	NULL
protein	NULL
CIHITAAah12	NULL
could	NULL
block	NULL
activity	NULL
of	NULL
wild-type	NULL
CIHITA	NULL
on	NULL
the	NULL
DRA	NULL
promoter	NULL
provides	NULL
a	NULL
further	NULL
indication	NULL
that	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
the	NULL
molecule	NULL
is	NULL
involved	NULL
in	NULL
promoter	NULL
targeting	NULL
.	NULL

The	NULL
second	NULL
protein-protein	NULL
interaction	NULL
is	NULL
between	NULL
the	NULL
B	NULL
cell-specific	NULL
co-activator	NULL
Bobl	NULL
(	NULL
OBF-1	NULL
,	NULL
OCA-B	NULL
)	NULL
(	NULL
43-45	NULL
)	NULL
and	NULL
CIITA	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
result	NULL
of	NULL
this	NULL
interaction	NULL
may	NULL
be	NULL
to	NULL
increase	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
by	NULL
virtue	NULL
of	NULL
an	NULL
additional	NULL
activation	NULL
domain	NULL
being	NULL
presented	NULL
by	NULL
CIITA	NULL
.	NULL

The	NULL
third	NULL
protein-protein	NULL
contact	NULL
is	NULL
between	NULL
CIITA	NULL
and	NULL
the	NULL
general	NULL
transcriptional	NULL
apparatus	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
this	NULL
occurs	NULL
at	NULL
TAFpg32	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL
)	NULL

.	NULL

Identification	NULL
of	NULL
the	NULL
two	NULL
a-helices	NULL
which	NULL
are	NULL
the	NULL
precise	NULL
contact	NULL
points	NULL
with	NULL
TAFg32	NULL
provides	NULL
an	NULL
extremely	NULL
useful	NULL
target	NULL
for	NULL
potential	NULL
exogenous	NULL
manipulation	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

Aside	NULL
from	NULL
using	NULL
the	NULL
dominant	NULL
negative	NULL
CIHITAAah12	NULL
,	NULL
small	NULL
molecules	NULL
which	NULL
mimic	NULL
the	NULL
structure	NULL
of	NULL
ah	NULL
1	NULL
and/or	NULL
ah2	NULL
could	NULL
potentially	NULL
block	NULL
the	NULL
function	NULL
of	NULL
CITA	NULL
specifically	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
aberrant	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
contributes	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
autoimmune	NULL
inflammatory	NULL
diseases	NULL
(	NULL
3	NULL
)	NULL
,	NULL
such	NULL
reagents	NULL
would	NULL
be	NULL
of	NULL
great	NULL
benefit	NULL
in	NULL
treating	NULL
these	NULL
conditions	NULL
.	NULL

Our	NULL
results	NULL
to	NULL
date	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
CIITA	NULL
may	NULL
itself	NULL
be	NULL
functioning	NULL
as	NULL
a	NULL
TAF	NULL
and	NULL
that	NULL
its	NULL
interaction	NULL
with	NULL
TAFg32	NULL
represents	NULL
the	NULL
primary	NULL
contact	NULL
point	NULL
between	NULL
CIITA	NULL
and	NULL
TFIID	NULL
.	NULL

Recent	NULL
reports	NULL
identifying	NULL
a	NULL
B	NULL
cell-specific	NULL
TAF	NULL
(	NULL
47	NULL
)	NULL
and	NULL
the	NULL
observations	NULL
that	NULL
the	NULL
large	NULL
T	NULL
antigen	NULL
of	NULL
SV40	NULL
virus	NULL
(	NULL
48	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pX	NULL
protein	NULL
of	NULL
HBV	NULL
(	NULL
49	NULL
)	NULL
may	NULL
function	NULL
as	NULL
TAFs	NULL
make	NULL
this	NULL
possibility	NULL
intriguing	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
CIHITA	NULL
in	NULL
a	NULL
cell	NULL
may	NULL
potentially	NULL
create	NULL
'class	NULL
II-tropic	NULL
'	NULL
TFIID	NULL
complexes	NULL
,	NULL
which	NULL
would	NULL
promote	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
from	NULL
target	NULL
genes	NULL
.	NULL

In	NULL
this	NULL
way	NULL
,	NULL
large	NULL
groups	NULL
of	NULL
genes	NULL
responsible	NULL
for	NULL
most	NULL
aspects	NULL
of	NULL
antigen	NULL
presentation	NULL
could	NULL
be	NULL
activated	NULL
in	NULL
a	NULL
global	NULL
manner	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
thank	NULL
Michael	NULL
Armanini	NULL
for	NULL
expert	NULL
secretarial	NULL
assistance	NULL
,	NULL
Nabila	NULL
Jabrane-Ferrat	NULL
and	NULL
Chuck	NULL
Toth	NULL
for	NULL
many	NULL
helpful	NULL
suggestions	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Peterlin	NULL
Laboratory	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Robert	NULL
Tjian	NULL
and	NULL
James	NULL
Goodrich	NULL
for	NULL
plasmid	NULL
pGEX2TK/TAFpq32	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Treadwell	NULL
Foundation	NULL
.	NULL

J.D.F	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Post-doctoral	NULL
Fellowship	NULL
grant	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
.	NULL

REFERENCES	NULL
Lillie	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
338	NULL
,	NULL
39-44	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
16	NULL
,	NULL
539-546	NULL
.	NULL

Guardiola	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Maffei	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
247-268	NULL
.	NULL

Abdulkadit	NULL
,	NULL
S.A	NULL
.	NULL

and	NULL
Ono,8.J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
FASEB	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
1429-1435	NULL
.	NULL

Sartoris	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Accolla	NULL
,	NULL
R.S	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
25	NULL
,	NULL
71-78	NULL
.	NULL

Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

and	NULL
Kara	NULL
,	NULL
C.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
13-49	NULL
.	NULL

Ting.J.P	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
(	NULL
1993	NULL
)	NULL
Curr	NULL
:	NULL
Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
5	NULL
,	NULL
8-16	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Otten	NULL
,	NULL
L.A.	NULL
,	NULL
Zufferey	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
,	NULL
75	NULL
,	NULL
135-146	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Siegrist	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Lisowska-Grospierre	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
,	NULL
265	NULL
,	NULL
106-109.	NULL
co	NULL
«	NULL
1	NULL
A	NULL
(	NULL
r	NULL
B	NULL
te	NULL
bo	NULL
i	NULL
\o	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
41	NULL
42	NULL
43	NULL
45	NULL
46	NULL
47	NULL
48	NULL
49	NULL
Chang	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
Fontes	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Peterlin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
180	NULL
,	NULL
1367-1374	NULL
.	NULL

Silacci	NULL
,	NULL
P.	NULL
,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
180	NULL
,	NULL
1329-1336	NULL
.	NULL

Kem	NULL
,	NULL
L.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.-A	NULL
.	NULL

and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
1295-1300	NULL
.	NULL

Chang	NULL
,	NULL
C.H	NULL
.	NULL

and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
765-767	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
,	NULL
Guerder	NULL
,	NULL
S.	NULL
,	NULL
Hong	NULL
,	NULL
S.C.	NULL
,	NULL
van	NULL
Ewijk	NULL
,	NULL
W.	NULL
and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
,	NULL
4	NULL
,	NULL
167-178	NULL
.	NULL

Riley	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Westerheide	NULL
,	NULL
$	NULL
.D	NULL
.	NULL

,	NULL
Price	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Brown	NULL
,	NULL
J.A	NULL
.	NULL

and	NULL
Boss	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
,	NULL
2	NULL
,	NULL
533-543	NULL
.	NULL

Zhou	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
,	NULL
2	NULL
,	NULL
545-553	NULL
.	NULL

Sadowski	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Ptashne	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
7539	NULL
.	NULL

Tsang,8	NULL
.	NULL

Y.	NULL
,	NULL
Nakanishi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
711-719	NULL
.	NULL

Klemm	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
Goodrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Zhou,8	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
5788-5792	NULL
.	NULL

Jabrane-Fertrat	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
7314-7321	NULL
.	NULL

Herrmann	NULL
,	NULL
C.H	NULL
.	NULL

and	NULL
Rice	NULL
,	NULL
A.P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
1612-1620	NULL
.	NULL

Shapiro	NULL
,	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
,	NULL
Wahli	NULL
,	NULL
W	NULL
.	NULL

and	NULL
Keller	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
DNA	NULL
,	NULL
7	NULL
,	NULL
47-53	NULL
.	NULL

Ma	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
48	NULL
,	NULL
847-853	NULL
.	NULL

Massari	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
Jennings	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Murre	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
121-129	NULL
.	NULL

Giniger,6	NULL
.	NULL

and	NULL
Ptashne	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
330	NULL
,	NULL
670-672	NULL
.	NULL

Hope	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
Mahadevan	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Struhl	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
333	NULL
,	NULL
635-640	NULL
.	NULL

Ma	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
51	NULL
,	NULL
113-119	NULL
.	NULL

Leuther	NULL
,	NULL
K.K	NULL
.	NULL

,	NULL
Salmeron	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Johnston	NULL
,	NULL
S.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
,	NULL
72	NULL
,	NULL
575-585	NULL
.	NULL

Van	NULL
Hoy	NULL
,	NULL
M.	NULL
,	NULL
Leuther	NULL
,	NULL
K.K	NULL
.	NULL

,	NULL
Kodadek	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Johnston	NULL
,	NULL
S.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
,	NULL
72	NULL
,	NULL
587-594	NULL
.	NULL

Cress	NULL
,	NULL
W.D	NULL
.	NULL

and	NULL
Triezenberg,8.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
,	NULL
251	NULL
,	NULL
87-90	NULL
.	NULL

Parada	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Yoon	NULL
,	NULL
J.B	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
2274-2283	NULL
.	NULL

Breiding	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
Grossel	NULL
,	NULL
M.J.	NULL
and	NULL
Androphy	NULL
,	NULL
E.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Virology	NULL
,	NULL
221	NULL
,	NULL
34-43	NULL
.	NULL

Blair	NULL
,	NULL
W.S	NULL
.	NULL

,	NULL
Bogerd	NULL
,	NULL
H.P	NULL
.	NULL

,	NULL
Madore	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
7226-7234	NULL
.	NULL

Trautwein	NULL
,	NULL
C.	NULL
,	NULL
Walker	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Plumpe	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Manns	NULL
,	NULL
M.P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
15130-15136	NULL
.	NULL

Berger	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Cress	NULL
,	NULL
W.D	NULL
.	NULL

,	NULL
Cress	NULL
,	NULL
A.	NULL
,	NULL
Triezenberg,8.J	NULL
.	NULL

and	NULL
Guarente	NULL
.	NULL

,	NULL
L	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
61	NULL
,	NULL
1199-1208	NULL
.	NULL

Lin	NULL
,	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Elenbaas	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Levine	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genes	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
1235-1246	NULL
.	NULL

Drysdale	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Duenas	NULL
,	NULL
E.	NULL
,	NULL
Jackson	NULL
,	NULL
B.M	NULL
.	NULL

,	NULL
Reusser	NULL
,	NULL
U.	NULL
,	NULL
Braus	NULL
,	NULL
G.H	NULL
.	NULL

and	NULL
Hinnebusch	NULL
,	NULL
A.G	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
1220-1233	NULL
.	NULL

Jabrane-Ferrat	NULL
,	NULL
N.	NULL
,	NULL
Fontes	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Boss	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
4683-4690	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Siegrist	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
554-558	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
,	NULL
Emery	NULL
,	NULL
P.	NULL
,	NULL
West	NULL
,	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
,	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Boss	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
,	NULL
4313-4321	NULL
.	NULL

Wright	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
Vilen	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Itoh-Lindstrom	NULL
,	NULL
Y.	NULL
,	NULL
Moore	NULL
,	NULL
Li	NULL
,	NULL
G.	NULL
,	NULL
Criscitiello	NULL
,	NULL
M.	NULL
,	NULL
Cogswell	NULL
,	NULL
P.	NULL
,	NULL
Clarke	NULL
,	NULL
J.B	NULL
.	NULL

and	NULL
Ting	NULL
,	NULL
J.P	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
4042-4053	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
,	NULL
Hadam	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Reith	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
1021-1032	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Knoepfel	NULL
,	NULL
L.	NULL
,	NULL
Georgiev,0	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
W.	NULL
and	NULL
Hovens	NULL
,	NULL
C.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
,	NULL
373	NULL
,	NULL
360-362	NULL
.	NULL

Luo	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
4115-4124	NULL
.	NULL

Strubin	NULL
,	NULL
M.	NULL
,	NULL
NewelL	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Matthias	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
,	NULL
80	NULL
,	NULL
497-506	NULL
.	NULL

Fontes	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Jabrane-Ferrat	NULL
,	NULL
N.	NULL
,	NULL
Toth	NULL
,	NULL
C.R	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
183	NULL
,	NULL
2517-2521	NULL
.	NULL

Dikstein	NULL
,	NULL
R.	NULL
,	NULL
Zhou	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
,	NULL
87	NULL
,	NULL
137-146	NULL
.	NULL

Damania	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Alwine	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Genes	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
1369-1381	NULL
.	NULL

Haviv.L	NULL
.	NULL

,	NULL
Vaizel	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Shaul	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
3413-3420	NULL
.	NULL

